Angelini

Angelini Industries is an Italian family-owned industrial group, founded in Italy in 1919 by Francesco Angelini and still led by the family, operating in 21 countries with about 5,600 employees and revenues of EUR 1.7 billion in 2025 across three sectors. Health is 75 percent of revenue: Angelini Pharma researches and markets medicines focused on brain health - mental health and epilepsy - alongside specialty, primary and consumer care, with 2,800 employees, four plants, direct presence in 20 countries and products sold in more than 70, and it discovered the active ingredients trazodone and benzydamine; Angelini Ventures is the group's EUR 300 million corporate venture arm investing in biotech, medtech and digital health. Industrial technology is 23 percent, through Angelini Technologies and Fameccanica (founded 1975), which build machinery for the industrial-scale production of household and personal-care goods, logistics applications and batteries. Consumer goods covers the 50-50 Procter & Gamble joint venture Fater - Pampers, Lines and ACE, and the Amuchina and Infasil brands from January 2026 - plus the six wineries of Angelini Wines & Estates.

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.